Trusted Resources: Community Center
A Guide to Understanding MPS I
MPS I is a mucopolysaccharide disease also called Hurler, Hurler-Scheie and Scheie syndrome. Hurler takes its name from Gertrude Hurler, the doctor who described a boy and girl with the condition in 1919. In 1962, Dr. Scheie, a consultant ophthalmologist, wrote about patients who were more mildly affected. Individuals who do not fit the severe or mild ends of the disease were said to have Hurler/Scheie.
The specific disease names have been replaced with the designations attenuated (diminished severity) and severe MPS I. MPS I has a wide range of symptoms that vary in severity and can be managed and treated with enzyme replacement therapies. There is no cure for MPS I.
BookmarkRelated Content
-
Mucopolysaccharidosis Market: Global Industry Analysis and Opportunity Assessment 2022-2029The wide ranging Mucopolysaccharidosis M...
-
UPMC Children’s Hospital of Pittsburgh – Center for Rare Disease TherapyHurler syndrome (mucopolysaccharidosis t...
-
Joseph Muenzer, MD, PhDJoseph Muenzer, MD, PhD is a Professor i...
-
Emily Wants to Show Other Caregivers the Importance of Taking Care of YourselfPeople often make admiring comments to c...
-
Luna and Partners Work to Accelerate Therapies for Hunter SyndromeAdvocacy organizations—the National MP...
-
How One Mother Turned Her Son’s Rare Disease Diagnosis Into an Opportunity to Help OthersMoira Taffarello and her husband have ex...
-
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Market Research Report – Global Clinical Trials Review, H2, ...The "Mucopolysaccharidosis I (MPS I) (Hu...
